best glp-1 drugs for weight loss Pills: Which One Is Right You? You might know them as
Description
In a phase 1b trial, 20 weeks of cagrilintide 2.4 mg once weekly in combination with semaglutide 2.4 mg once weekly (cagrisema) resulted in up to 17.1% WL compared to 9.5% WL with semaglutide 2.4 mg plus placebo in people with obesity [88]
Semaglutide: a medicine to manage type 2 diabetes or treat obesity
No, the FDA has not approved GLP-1 patches
Animal and in vitro studies were excluded
PMC 310948
